Clinical Trial Update: A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of YAZ (drospirenone/ethinyl estradiol) versus placebo for hidradenitis suppurativa was terminated with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• YAZ (drospirenone/ethinyl estradiol) (drospirenone/ethinyl estradiol)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: TERMINATED | Results posted: 2014-01-16